Biological E. Limited Sodium Export Data — India (DGFT 2022–2026)

Name: Biological E. Limited Sodium Export Records India — #15 Exporter, 99 Shipments, $5.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Sodium

India Pharmaceutical Trade Intelligence

$361.2M985 Suppliers177 CountriesHS 30049099

ExportsIndia → UNITED STATES40.4%India → CANADA2.9%

ImportsCHINA → India$510.0B BELGIUM → India$3.4B

#1 Supplier: EUGIA PHARMA #1 Buyer: AUROLOGISTICS LLC

Biological E. Limited — Sodium Exporter #15 | $5.0M Trade Value | TransData Nexus | TransData Nexus

Biological E. Limited — Sodium Exporter Profile

Indian Pharmaceutical Exporter · #15 for Sodium · $5.0M export value · DGFT Verified

Biological E. Limited is the #15 Indian exporter of Sodium with $5.0M in export value and 99 verified shipments. Biological E. Limited holds a 1.4% market share in Sodium exports across 2 countries. The company exports 5 pharmaceutical products worth $80.3M across 3 therapeutic categories.

Biological E. Limited — Sodium Export Profile: Buyers & Destinations

Biological E. Limited Sodium export treemap — buyers and destination countries | TransData Nexus

Where Does Biological E. Limited Export Sodium?

Country	Value	Shipments	Share
UNITED STATES	$8.2M	179	62.0%
CANADA	$4.4M	112	33.0%
THAILAND	$266.3K	7	2.0%
MEXICO	$250.0K	5	1.9%

Who Are the Top Buyers of Sodium from Biological E. Limited?

Buyer	Country	Value	Orders
BE PHARMACEUTICALS INC	UNITED STATES	$7.3M	155
FRESENIUS KABI CANADA LTD	CANADA	$3.5M	89
BE PHARMACEUTICALS INC.	UNITED STATES	$987.2K	24
FRESENIUS KABI CANADA LTD.	CANADA	$566.6K	12
STADA(THAILAND) COMPANY LIMIT 8T	THAILAND	$224.7K	6
FRESENIUS KABI CANADA LIMITED	CANADA	$164.5K	5
STERIMAX INC	CANADA	$150.0K	3
CARITAS PHARMA S.A DE C.V	MEXICO	$150.0K	3
CARITAS PHARMA S A DE C V	MEXICO	$100.0K	2
MINISTERIO DE SALUD	PANAMA	$100.0K	2

Biological E. Limited supplies Sodium to 19 buyers globally. The largest buyer is BE PHARMACEUTICALS INC (UNITED STATES), followed by FRESENIUS KABI CANADA LTD (CANADA) and BE PHARMACEUTICALS INC. (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Sodium Formulations Does Biological E. Limited Export?

Product Description / Formulation	Value	Shipments
ENOXAPARIN SODIUM INJECTION USP 40MG/0.4ML	$1.8M	36
51000441 - ENOXAPARIN SODIUM INJECTION,	$1.1M	24
51000440 - ENOXAPARIN SODIUM INJECTION,	$616.1K	14
ENOXAPARIN SODIUM INJECTION USP 40MG/0.4MLNOS	$553.9K	14
51000444 - ENOXAPARIN SODIUM INJECTION,	$462.3K	14
ENOXAPARIN SODIUM INJECTION USP 30MG/0.3ML	$412.2K	9
ENOXAPARIN SODIUM INJECTION USP 60MG/0.6ML	$348.1K	8
51000446 - ENOXAPARIN SODIUM INJECTION,	$300.0K	6
ENOXAPARIN SODIUM INJECTION USP 80MG/0.8ML	$300.0K	6
55000225 - PANTOPRAZOLE SODIUM INJ 40MG/	$298.5K	10

Biological E. Limited exports 96 distinct Sodium formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ENOXAPARIN SODIUM INJECTION USP 40MG/0.4ML with 36 shipments worth $1.8M.

How Does Biological E. Limited Compare to Nearest Sodium Exporters?

Exporters ranked immediately above and below #15 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
10	MACLEODS PHARMACEUTICALS LTD	$5.7M	113	31	$50.0K
11	ENCUBE ETHICALS PRIVATE LIMITED	$5.7M	113	1	$50.0K
15	BIOLOGICAL E. LIMITED ★	$5.0M	99	2	$50.0K
13	MACLEODS PHARMACEUTICALS LIMITED	$1.0M	20	12	$50.0K

Biological E. Limited ranks #15 among 985 Indian Sodium exporters. Average shipment value of $50.0K compared to the market average of $147.6K. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and ENCUBE ETHICALS PRIVATE LIMITED.

Which Indian Ports Ship Sodium Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	2,869	19.1%
SAHAR AIR CARGO ACC (INBOM4)	1,813	12.1%
DELHI AIR CARGO ACC (INDEL4)	1,734	11.6%
JNPT	844	5.6%
HYDERABAD ICD (INSNF6)	804	5.4%
Bombay Air	617	4.1%
AHEMDABAD ICD (INSBI6)	445	3.0%
Delhi Air	431	2.9%

Geopolitical & Trade Policy Impact on Biological E. Limited's Sodium Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like BE. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight charges and potential losses estimated between ₹2,500 crore and ₹5,000 crore for the Indian pharma industry in March 2026. (fortuneindia.com) These disruptions can elongate lead times and elevate cold-chain failure risks, particularly for temperature-sensitive products like vaccines. (pharmaceuticalcommerce.com)

Conversely, U.S.-China trade tensions have prompted the U.S. to seek alternative suppliers, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the U.S. in August 2025 posed challenges, with Indian exporters facing increased costs and competitive disadvantages. (apnews.com) The subsequent withdrawal of tariffs on generic drugs in October 2025 provided some relief, yet the episode underscores the volatility of trade policies and the need for exporters to remain agile. (medboundtimes.com)

In the European Union, compliance with the Falsified Medicines Directive requires stringent serialization and traceability measures. For companies like BE, ensuring adherence to these regulations is crucial to maintain market access and uphold their reputation for quality.

Biological E. Limited — Regulatory Compliance & Quality Standards

Regulatory compliance remains a cornerstone for Indian pharmaceutical exporters. The U.S. FDA has intensified inspections, with over 200 conducted in 2023 and plans to increase this number in 2024. (fact.net.in) Instances of quality issues and FDA warnings have previously affected the reputation of Indian pharma exports. (svhealthcare.in) For BE, maintaining compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP) is imperative to sustain and expand its export footprint.

The company's recent WHO pre-qualification for nOPV2 reflects its commitment to quality and regulatory excellence. However, the broader industry faces challenges related to counterfeit drugs and quality concerns, which can impact India's reputation as a reliable supplier. (fact.net.in) Proactive measures, including robust quality assurance systems and transparent governance, are essential for BE to navigate this evolving landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Sodium shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Biological E. Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 311 individual customs records matching Biological E. Limited exporting Sodium, covering 96 formulations to 10 countries via 19 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 177+ countries, 2,469+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Sodium

Sodium

Biological E. Limited — Sodium Exporter Profile

Biological E. Limited — Sodium Export Profile: Buyers & Destinations

Where Does Biological E. Limited Export Sodium?

Who Are the Top Buyers of Sodium from Biological E. Limited?

What Is India's Total Sodium Export Value and How Much Does Biological E. Limited Contribute?

What Is the Average Shipment Value for Biological E. Limited's Sodium Exports?

How Does Biological E. Limited Compare to Other Indian Sodium Exporters?

What Sodium Formulations Does Biological E. Limited Export?

Regulatory Requirements: Exporting Sodium to Key Markets

United States — FDA

Canada — HC

How Does Biological E. Limited Compare to Nearest Sodium Exporters?

Which Indian Ports Ship Sodium Exports?

Geopolitical & Trade Policy Impact on Biological E. Limited's Sodium Exports

Biological E. Limited — Regulatory Compliance & Quality Standards

About Biological E. Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Sodium Export Data from Biological E. Limited

Sodium Stats

Company Overview

Top Products by Biological E. Limited

Related Analysis

Need Detailed Export Data?

Data Source